Have a personal or library account? Click to login
High Sensitivity C-Reactive Protein Predictive Value for Cardiovascular Disease: A Nested Case Control from Isfahan Cohort Study (ICS) Cover

High Sensitivity C-Reactive Protein Predictive Value for Cardiovascular Disease: A Nested Case Control from Isfahan Cohort Study (ICS)

Global Heart
Volume 15 (2020): Issue 1
By: Pooya Koosha,  Hamidreza Roohafza,  Nizal Sarrafzadegan,  Mehrbod Vakhshoori,  Mohammad Talaei,  Erfan Sheikhbahaei and  Masoumeh Sadeghi  
Open Access
|Feb 2020

References

  1. 1Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349: 1269–76. http://www.sciencedirect.com.ez.lshtm.ac.uk/science/article/pii/S0140673696074934. DOI: 10.1016/S0140-6736(96)07493-4
    Back to article
  2. 2Leal J, Luengo-Fernández R, Gray A, et al. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006; 27: 1610–9. DOI: 10.1093/eurheartj/ehi733
    Back to article
  3. 3Talaei M, Oveisgharan S, Rabiei K, et al. The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an Iranian population: The Isfahan Cohort Study. Adv Biomed Res. 2014; 3: 242. DOI: 10.4103/2277-9175.145749
    Back to article
  4. 4Rubinstein AL, Irazola VE, Poggio R, et al. Detection and follow-up of cardiovascular disease and risk factors in the Southern Cone of Latin America: The CESCAS I study. BMJ Open. 2011; 1: 1–6. DOI: 10.1136/bmjopen-2011-000126
    Back to article
  5. 5Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837–47. DOI: 10.1161/01.CIR.97.18.1837
    Back to article
  6. 6Beaglehole R, Magnus P. The search for new risk factors for coronary heart disease: Occupational therapy for epidemiologists? Int J Epidemiol. 2002; 31: 1117–22. DOI: 10.1093/ije/31.6.1117
    Back to article
  7. 7Khot UN, Khot MB, Bajzer CT, et al. Prevalence of Conventional Risk Factors in Patients with Coronary Heart Disease. J Am Med Assoc. 2003; 290(7): 898–904. DOI: 10.1001/jama.290.7.898
    Back to article
  8. 8Ridker PM, Brown NJ, Vaughan DE, et al. Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events. Circulation. 2004; 109: IV-6–IV-19. DOI: 10.1161/01.CIR.0000133444.17867.56
    Back to article
  9. 9Alie N, Eldib M, Fayad ZA, et al. Clinical Medicine Insights: Cardiology Evaluation of Atherosclerosis and Inflammation. Am J Epidemiol, 2014; 8: 13–21. DOI: 10.4137/CMC.S17063
    Back to article
  10. 10Bilhorn KR, Luo Y, Lee BT, et al. High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults. Am J Cardiol. 2012; 110: 1464–7. DOI: 10.1016/j.amjcard.2012.06.056
    Back to article
  11. 11Lee JH, Yang DH, Park HS, et al. Incremental predictive value of high-sensitivity C-reactive protein for incident hypertension: The Hypertension-Diabetes Daegu Initiative study. Clin Exp Hypertens. 2014; 36: 302–8. DOI: 10.3109/10641963.2013.810236
    Back to article
  12. 12Nabipour I, Vahdat K, Jafari SM, et al. Elevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: The Persian Gulf healthy heart study. Endocr J. 2008; 55: 717–22. DOI: 10.1507/endocrj.K08E-026
    Back to article
  13. 13Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-Associated Phospholipase A 2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2004; 109: 837–42. DOI: 10.1161/01.CIR.0000116763.91992.F1
    Back to article
  14. 14Koenig W, Löwel H, Baumert J, et al. C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score – Implications for Future Risk Assessment: Results from a Large Cohort Study in Southern Germany. Circulation. 2004; 109: 1349–53. DOI: 10.1161/01.CIR.0000120707.98922.E3
    Back to article
  15. 15Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351: 2599–610. DOI: 10.1056/NEJMoa040967
    Back to article
  16. 16Ridker PM, Rifai N, Rose L, et al. Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347: 1557–65. DOI: 10.1056/NEJMoa021993
    Back to article
  17. 17Khaledi Y, Aghababaei E, Sadeghi M, et al. Evaluation of heart rate reserve and high-sensitivity C-reactive protein in individuals with and without metabolic syndrome in Isfahan, Iran. ARYA Atheroscler. 2012; 8: 70–5.
    Back to article
  18. 18Wang X, Du YZ, Fan L, et al. Relationships between HDL-C, hs-CRP, with central arterial stiffness in apparently healthy people undergoing a general health examination. PLoS One. 2013; 8: 1–7. DOI: 10.1371/journal.pone.0081778
    Back to article
  19. 19Xue H, Wang J, Hou J, et al. Association of ideal cardiovascular metrics and serum high-sensitivity C-reactive protein in hypertensive population. PLoS One. 2013; 8: 8–12. DOI: 10.1371/journal.pone.0081597
    Back to article
  20. 20Faradonbeh NA, Nikaeen F, Akbari M, et al. Cardiovascular disease risk prediction among iranian patients with diabetes mellitus in Isfahan province, Iran, in 2014, by using framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein. ARYA Atheroscler. 2018; 14: 163–8. DOI: 10.22122/arya.v14i4.1685
    Back to article
  21. 21Sarrafzadegan N, Talaei M, Sadeghi M, et al. The Isfahan cohort study: Rationale, methods and main findings. J Hum Hypertens. 2011; 25: 545–53. DOI: 10.1038/jhh.2010.99
    Back to article
  22. 22Kazemi-Saleh D, Koosha P, Sadeghi M, et al. Predictive role of adiponectin and high-sensitivity C-reactive protein for prediction of cardiovascular event in an Iranian cohort study: The Isfahan Cohort study. ARYA Atheroscler. 2016; 12: 132–7.
    Back to article
  23. 23Khosravi-boroujeni H, Ahmed F, Sadeghi M, et al. Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions? BMC Public Health. 2016; 1–8. DOI: 10.1186/s12889-015-2623-3
    Back to article
  24. 24Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome Executive Summary. Curr Opin Cardiol. 2006; 21: 1–6. DOI: 10.1161/CIRCULATIONAHA.105.169404
    Back to article
  25. 25Ebrahimi M, Heidari-Bakavoli AR, Shoeibi S, et al. Association of Serum hs-CRP Levels With the Presence of Obesity, Diabetes Mellitus, and Other Cardiovascular Risk Factors. J Clin Lab Anal. 2016; 30: 672–6. DOI: 10.1002/jcla.21920
    Back to article
  26. 26Wang Z, Wang X, Chen Z, et al. Distribution of high-sensitivity C-reactive protein and its relationship with other cardiovascular risk factors in the middle-aged Chinese population. Int J Environ Res Public Health. 2016; 13. DOI: 10.3390/ijerph13090872
    Back to article
  27. 27Kianoush S, Bittencourt M, Lotufo P, et al. Association between smoking and serum GlycA and high-sensitivity C-reactive protein levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Am Heart Assoc. 2017; 6. DOI: 10.1161/JAHA.117.006545
    Back to article
  28. 28Hung M, Hung M, Hsu K, et al. Interaction Between Cigarette Smoking and High-Sensitivity C-Reactive Protein in the Development of Coronary Vasospasm in Patients Without Hemodynamically Significant Coronary Artery Disease. Am J Med Sci. 2009; 338: 440–6. DOI: 10.1097/MAJ.0b013e3181b9147f
    Back to article
  29. 29Kawamoto R, Kusunoki T, Abe M, et al. An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons. Ann Clin Biochem. 2013; 50: 457–64. DOI: 10.1177/0004563212473445
    Back to article
  30. 30Nishitani N, Sakakibara H. Association between body mass index and high-sensitivity C-reactive protein in male Japanese. Obes Res Clin Pract. 2013; 7: e297–300. DOI: 10.1016/j.orcp.2012.02.004
    Back to article
  31. 31Guldiken S, Demir M, Arikan E, et al. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res. 2007; 119: 79–84. DOI: 10.1016/j.thromres.2005.12.019
    Back to article
  32. 32Ding D, Wang M, Su D, et al. Body mass index, high-sensitivity C-reactive protein and mortality in Chinese with coronary artery disease. PLoS One. 2015; 10: 1–11. DOI: 10.1371/journal.pone.0135713
    Back to article
  33. 33Lin CC, Kardia SLR, Li CI, et al. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health. 2010; 10. DOI: 10.1186/1471-2458-10-579
    Back to article
  34. 34Sathiyapriya V, Selvaraj N, Nandeesha H, et al. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: A possible indication of underlying cardiovascular risk. Clin Exp Hypertens. 2008; 30: 367–74. DOI: 10.1080/10641960802275106
    Back to article
  35. 35Choi H, Cho DH, Shin HH, et al. Association of High Sensitivity C-Reactive Protein with Coronary Heart Disease Prediction, but not with Carotid Atherosclerosis, in Patients with Hypertension. Circ J. 2004; 68: 297–303. DOI: 10.1253/circj.68.297
    Back to article
  36. 36Wang C, Yatsuya H, Tamakoshi K, et al. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up. Diabetes Metab Res Rev. 2013; 29: 398–405. DOI: 10.1002/dmrr.2406
    Back to article
  37. 37Zaghloul A, Al-bukhari TAMA, AL-Pakistani HA, et al. Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: Their role in the prediction of vascular complications. Diabetes Res Clin Pract. 2014; 106: 597–604. DOI: 10.1016/j.diabres.2014.09.007
    Back to article
  38. 38Whelton SP, Roy P, Astor BC, et al. Elevated high-sensitivity c-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. Am J Epidemiol. 2013; 178: 1076–84. DOI: 10.1093/aje/kwt086
    Back to article
DOI: https://doi.org/10.5334/gh.367 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: May 23, 2019
Accepted on: Dec 10, 2019
Published on: Feb 6, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
high sensitivity C – reactive protein,
cardiovascular events,
inflammation,
Isfahan cohort study,
Odds ratio

© 2020 Pooya Koosha, Hamidreza Roohafza, Nizal Sarrafzadegan, Mehrbod Vakhshoori, Mohammad Talaei, Erfan Sheikhbahaei, Masoumeh Sadeghi, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 15 (2020): Issue 1Next article